Novo Nordisk’ chief executive Lars Fruergaard ... be the only industry representative in the GLP-1 agonist market to testify at the hearing. At ASCO 2025, BioNTech presented 7 abstracts on ...

Novo Nordisk CEO Lars Fruergaard Jorgensen has agreed ... Jorgensen this afternoon and thank him for voluntarily agreeing to testify,” Sanders said in the release. “The scheduled subpoena ...

as demand for both injections soars in the U.S. Novo Nordisk CEO Lars Fruergaard Jørgensen did not explicitly promise lawmakers at a Senate Health, Education, Labor and Pensions Committee ...

Bernie Sanders said the CEO of Novo Nordisk will testify on the cost of Ozempic and Wegovy. Lars Jørgensen will appear before the Senate Committee on Health, Education, Labor, and Pensions.

WASHINGTON — Sen. Bernie Sanders, I-Vt., on Tuesday extracted a meager commitment from Novo Nordisk CEO Lars Fruergaard Jørgensen to meet with pharmacy benefits managers to discuss lowering the ...

The CEO of Novo Nordisk plans to blame drug middlemen for ... Jorgensen agreed in June to testify, after Sanders had threatened him with a subpoena. “The American people are sick and tired ...

Sept. 24 (UPI) --The CEO of Novo Nordisk is on Capitol Hill Tuesday to testify before a Senate committee about the high costs of its drugs Ozempic and Wegovy. Chairman Sen. Bernie Sanders ...

After some persuasion from Sen. Bernie Sanders (I-Vt.), the CEO of Novo Nordisk will testify before lawmakers later this year on the "outrageously high cost" of the company's diabetes and weight ...

Novo Nordisk, the maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by "mutual agreement" with the company's board of directors, citing "recent market challenges ...

(Reuters) -As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for a leader deeply entrenched in the United States, by far its ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the ...